Back to Search
Start Over
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care – 2-year outcomes and predictors.
- Source :
- Rheumatology; Jan2019, Vol. 58 Issue 1, p110-119, 10p, 2 Diagrams, 3 Charts, 1 Graph
- Publication Year :
- 2019
-
Abstract
- Objectives A cohort of routine care RA patients in sustained remission had biological DMARD (bDMARDs) tapered according to a treatment guideline. We studied: the proportion of patients whose bDMARD could be successfully tapered or discontinued; unwanted consequences of tapering/discontinuation; and potential baseline predictors of successful tapering and discontinuation. Methods One-hundred-and-forty-three patients (91% receiving TNF inhibitor and 9% a non-TNF inhibitor) with sustained disease activity score (DAS28-CRP)⩽2.6 and no radiographic progression the previous year were included. bDMARD was reduced to two-thirds of standard dose at baseline, half after 16 weeks, and discontinued after 32 weeks. Patients who flared (defined as either DAS28-CRP ⩾ 2.6 and ΔDAS28-CRP ⩾ 1.2 from baseline, or erosive progression on X-ray and/or MRI) stopped tapering and were escalated to the previous dose level. Results One-hundred-and-forty-one patients completed 2-year follow-up. At 2 years, 87 patients (62%) had successfully tapered bDMARDs, with 26 (18%) receiving two-thirds of standard dose, 39 (28%) half dose and 22 (16%) having discontinued; and 54 patients (38%) were receiving full dose. ΔDAS28-CRP<subscript>0-2yrs</subscript> was 0.1((−0.2)-0.4) (median (interquartile range)) and mean ΔTotal-Sharp-Score<subscript>0-2yrs</subscript> was 0.01(1.15)(mean(s. d.)). Radiographic progression was observed in nine patients (7%). Successful tapering was independently predicted by: ⩽1 previous bDMARD, male gender, low baseline MRI combined inflammation score or combined damage score. Negative IgM-RF predicted successful discontinuation. Conclusion By implementing a clinical guideline, 62% of RA patients in sustained remission in routine care were successfully tapered, including 16% successfully discontinued at 2 years. Radiographic progression was rare. Maximum one bDMARDs, male gender, and low baseline MRI combined inflammation and combined damage scores were independent predictors for successful tapering. [ABSTRACT FROM AUTHOR]
- Subjects :
- RHEUMATOID arthritis diagnosis
RHEUMATOID arthritis treatment
ANTIRHEUMATIC agents
BIOTHERAPY
COMPUTED tomography
MAGNETIC resonance imaging
MEDICAL protocols
SEX distribution
TERMINATION of treatment
TUMOR necrosis factors
TREATMENT effectiveness
DISEASE remission
TREATMENT duration
CHEMICAL inhibitors
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 14620324
- Volume :
- 58
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 133582692
- Full Text :
- https://doi.org/10.1093/rheumatology/key244